[
    {
        "id": "osp-11522",
        "type": "article-journal",
        "title": "The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?",
        "author": [
            {
                "family": "Said",
                "given": "Elias A."
            }
        ],
        "URL": "https://omanscience.com/ar/articles/the-need-for-new-anti-hepatitis-c-virus-therapeutic-strategies-targeting-the-cellular-micro-ribonucleic-acids",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2025
                ]
            ]
        },
        "container-title": "Sultan Qaboos University Medical Journal",
        "volume": "10",
        "issue": "3",
        "page": "312-317",
        "DOI": "10.18295/2075-0528.1211",
        "publisher": "Sultan Qaboos University",
        "ISSN": "2075-051X",
        "abstract": "Infection with the hepatitis C virus (HCV) is a worldwide problem. Patients with chronic HCV infection who are non-responders to standard therapy represent a growing population within the HCV epidemic.Novel, more efficient and tolerable therapies are urgently needed. This review discusses the recent results showing that targeting miR-122, a micro-ribonucleic acid (MicroRNA) that enhances HCV replication, is a new anti-HCV therapy with a high barrier to resistance."
    }
]